We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Emapalumab Shows Promise As Targeted Therapy for Children Fighting Deadly Immune Disease

News   May 07, 2020 | Original story from Cincinnati Children's

 
Emapalumab Shows Promise As Targeted Therapy for Children Fighting Deadly Immune Disease

A laboratory technician at Cincinnati Children's conducts immunology testing for the severe childhood immune disorder HLH (hemophagocytic lymphohistiocytosis), which damages vital organs and tissues. Researchers report in the New England Journal of Medicine treating patients with a new drug that saved kid's lives with less toxicity and fewer side effects. Doctors hope the treatment will help dent HLH's high mortality rate. Credit: Cincinnati Children's

 
 
Advertisement
 

RELATED ARTICLES

Antibodies Can Attack SARS-CoV-2 Even When Their Spike Shape Changes

News

The spikes on the SARS-CoV-2 virus, which causes COVID-19, change shapes. New research reveals ways that antibodies can recognize these different shapes and block the virus and informs the design of vaccines and antiviral therapies.

READ MORE

Human Lung and Brain Organoids Respond Differently to SARS-CoV-2 Infection

News

Researchers are using stem cell-derived organoids to study how SARS-CoV-2 interacts with various organ systems and to develop therapies to block infection.

READ MORE

A Gene Serves Both a Protective and Destructive Role in Health

News

Researchers suggest that the gene ENDU-2 could be responsible for triggering tumors in the body. The team discovered that while under stress, ENDU-2 can contribute both to the protection of the organism and to its destruction.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE